(Q33390438)
Statements
1 reference
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer (English)
1 reference
Christopher Lobo
1 reference
Gilberto Lopes
1 reference
Odalys Baez
1 reference
Aurelio Castrellon
1 reference
Annapoorna Ferrell
1 reference
Connie Higgins
1 reference
Erin Hurley
1 reference
Judith Hurley
1 reference
Isildinha Reis
1 reference
Stephen Richman
1 reference
Pearl Seo
1 reference
Orlando Silva
1 reference
Joyce Slingerland
1 reference
Keleni Tukia
1 reference
Catherine Welsh
1 reference
Stefan Glück
1 reference
1 reference
Identifiers
1 reference